Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
horizontal line  
Search: 
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_

horizontal line
Topic Contents
 arrow Topic Home
  arrow About this Site
  arrow Diseases Connected to Antibiotic Resistance
  arrow Prevention Tools
  arrow CDC Surveillance Systems
  arrow Clinical Guidelines
  arrow Laboratory Information
  arrow Related Links
  arrow Glossary
  arrow Scientific and Other Publications
horizontal line

 

_
Antibiotic / Antimicrobial Resistance
HomeAction plan > Index
Action Plan — Index

Terms below are listed according to the Action Items in which they may be found. These and other terms may also be found in the Executive Summary, Top Priority Action Items, and Introduction and Overview sections of the document.

accreditation 7, 66
Agency for Healthcare Research and Quality (AHRQ)
  coordinator 11, 16
collaborator 21, 22, 34, 40, 62, 66, 68, 73, 76, 79, 80
agriculture 5, 13, 83, 84
  animal and plant health 19, 83
animal husbandry 50, 83
farms 17, 18 see also food safety
AHRQ see Agency for Healthcare Research and Quality
American Society for Microbiology (ASM) 43
antimicrobial drugs
  availability of 5, 12, 60, 79, 80, 82
discovery of 12, 80-82
stimulating resistance 20, 55, 83
gaps in the arsenal of drugs 5, 74, 75, 79
monitoring patterns of drug use 3, 4, 5, 22, 67
overuse and misuse of see appropriate use
prescribing 22, 23, 59, 60
susceptibility of 3, 8-13, 29-31, 35, 37
antimicrobial resistance (AR)
  communities, spread of AR in 63, 78
emergence of 3, 4, 20, 50, 51, 53, 55, 67, 70, 83-84
nonfederal partners 62, 63
the public, and 61-63
spread of 53, 55, 67, 70
appropriate use of antimicrobial drugs 21-27, 31-34, 43, 57, 59, 63, 64, 66, 76, 80
  promotion of 21, 22, 25, 26, 43, 63, 66, 80
ASM see American Society for Microbiology
bacteria 17, 18, 20, 33, 35, 46, 50, 52
behavioral change 24-26, 43
behavioral interventions see behavioral change
CDC see Centers for Disease Control and Prevention
Centers for Disease Control and Prevention (CDC)
  coordinator 1-26, 30-33, 35-48, 50, 55-57, 62-66, 68, 79, 80, 83
collaborator 27, 28, 34, 49, 51-54, 67, 72, 73, 75-78, 81
CLIA see Clinical Laboratory Improvement Amendments
clinical devices see medical devices and procedures
Clinical Laboratory Improvement Amendments (CLIA) 37
clinical trials 30, 35, 74, 75, 82
competitive exclusion products 83
computer-assisted decision support 24, 26
confidentiality 3, 5
consumer groups see consumers
consumer products 5, 42
consumers 27, 45
contamination
  bacterial 46, 52
environmental 19, 55 see also environmental impact
core capacities 13, 14
cross-infection see infection
daycare centers 25, 38
demonstration projects 2, 63
Department of Defense (DoD)
  coordinator 64, 65
collaborator 2, 3, 5, 21, 22, 24, 26, 33, 35, 38-40, 44, 62, 63, 67, 68, 70-78
Department of Veterans Affairs (DVA)
  coordinator 64, 65, 69
  collaborator 2, 3, 5, 21, 22, 24, 26, 33, 35, 38-41, 44, 48, 62, 63, 67, 68, 72-78
detection and reporting see surveillance
diagnosis 4, 5, 30
diagnostic tests and testing 13, 14, 33, 34, 37, 64, 66, 70, 75, 76, 79, 82
disinfectants 42, 75, 79
DoD see Department of Defense
drugs see antimicrobial drugs
DVA see Department of Veterans Affairs
economics 11, 34, 80
electronic surveillance see surveillance
environmental impact 67 see also contamination environmental
Environmental Protection Agency (EPA)
  coordinator 1, 3, 19, 20, 42, 55, 61
collaborator 5, 51, 52, 57, 62, 67, 68
EPA see Environmental Protection Agency
epidemiology 10, 51, 67, 79
extended care facilities 21, 38, 39
FDA see Food and Drug Administration
flu see influenza
Food and Drug Administration (FDA)
  coordinator 1-6, 9, 10, 13, 15, 17, 18, 23, 25-30, 33, 45, 50, 55, 57-60, 62, 68, 69, 72, 73, 76, 77, 79, 80, 82-84
collaborator 2, 3, 21, 22, 35, 40-42, 48, 49, 51-54, 63, 67, 70, 71, 74, 75, 78, 81
food safety 6, 17, 45, 46, 49-51, 53, 54, 58, 83
fungi 35, 67, 76
genetics see microbial genes and microbial genomics
growth promotants 49
guidelines, clinical 26, 35
HCFA see Healthcare Financing Administration
health care delivery 6, 7, 16, 22, 34, 36-42, 44, 63-65
  hospitals 21, 22, 24, 41, 48
managed care 32, 34
state and local health agencies 13, 14, 62, 63
Healthcare Financing Administration (HCFA)
  coordinator 7, 10, 11, 15, 31, 34, 64, 65
collaborator 2, 3, 8, 22, 24-26, 32, 35-37, 39, 40, 44, 48, 62, 63, 66, 68
Health Plan Employer Data and Information Set (HEDIS) 32
Health Resources and Services Administration (HRSA)
  coordinator 11, 64, 65
collaborator 3, 26, 31, 34, 35, 39, 40, 44, 62, 63
HEDIS see Health Plan Employer Data and Information Set
HIV/AIDS 82
host factors 67
HRSA see Health Resources and Services Administration
hygienic practices 43
immunization see vaccine
infection
  control 39, 44, 64, 66, 75
transmission 17, 30, 38, 43, 50, 77
influenza 48, 77
insurance 36
JCAHO see Joint Commission on Accreditation of Healthcare Organizations
Joint Commission on Accreditation of Healthcare Organizations (JCAHO) 66
labeling 4, 9, 29, 30
laboratories 2-4, 8-10, 12-14, 29, 30, 35, 36, 51
market incentives 34, 80, 81, 83
medical devices and procedures 40, 70
Medicare 24
microbial
  ecology 67, 78
genes 67, 76
genomics 70
microbiologists 79
microbiology 35, 37, 43
mold see mould
mould 10
National Committee for Clinical Laboratory Standards (NCCLS) 10, 29
National Committee for Quality Assurance (NCQA) 66
National Institutes of Health (NIH)
  coordinator 10, 33, 62, 67-78, 81, 83
collaborator 4, 79
NCCLS see National Committee for Clinical Laboratory Standards
NCQA see National Committee for Quality Assurance
NIH see National Institutes of Health
nongovernment surveillance see surveillance
outcomes see patient outcomes
outpatient 21
package inserts 27
parasites 10, 35, 76
patient outcomes 5, 16, 22, 24, 26, 67
Peer Review Organizations (PROs) 24
pesticide use 20, 61
pharmaceutical companies 74, 79
pharmacies 6, 48
pharmacodynamics 74, 82
pharmacokinetics 74, 82
pilot programs 80, 83
pilot studies 2, 19
pre-clinical studies 74, 82
Prevention and Control (Focus Area II) 21-66
Product Development (Focus Area IV) 79-84
products, new
  antimicrobials 58, 74, 75, 78, 79, 82-84
vaccines 77, 78, 82, 83
proficiency testing programs 8
PROs see Peer Review Organizations
public health education campaign 25, 43, 45, 46
quality assurance 7, 14, 26
reimbursement 31, 34
regulations 61, 82
regulatory process 82, 84
reporting see Surveillance (Focus Area I)
Research (Focus Area III) 67-78
resistance mechanisms 67
Surveillance (Focus Area I) 1-20
surveillance
  electronic 3
national plan 2
nongovernment 2
susceptibility data see antimicrobial drugs susceptibility
Top Priority Action Items 2, 5, 25, 26, 39, 58, 63, 70, 75-77, 79, 80
training programs 8, 26, 44, 72
treatment, novel 48, 70, 74, 75, 78-81
USDA see U.S. Department of Agriculture
U.S. Department of Agriculture (USDA)
  coordinator 1-6, 10, 13-15, 17-20, 45, 49-55, 57, 59, 60, 68, 79, 83, 84
collaborator 2, 3, 25, 62, 63, 67, 70-74, 76-78, 80-82
vaccination see vaccine
vaccine 47, 48, 64, 66, 77, 78, 79, 82, 83
veterinary medicine 2, 3, 5, 6, 13-15, 49-61, 63, 76, 77, 80, 83, 84
viral infection see viruses
viruses 10, 33, 35, 76, 77, 82
yeast 10

<<Previous | Table of Contents | Index

 

 

 

 
 
Date: April 4, 2006
Content source: National Center for Preparedness, Detection, and Control of Infectious Diseases/Division of Healthcare Quality Promotion
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
 Safer, Healthier People  USAGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435